|
US4443340A
(en)
|
1981-10-09 |
1984-04-17 |
Betz Laboratories, Inc. |
Control of iron induced fouling in water systems
|
|
US5100899A
(en)
|
1989-06-06 |
1992-03-31 |
Roy Calne |
Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
|
|
JPH04230389A
(ja)
|
1990-07-16 |
1992-08-19 |
American Home Prod Corp |
ラパマイシン誘導体
|
|
US5023262A
(en)
|
1990-08-14 |
1991-06-11 |
American Home Products Corporation |
Hydrogenated rapamycin derivatives
|
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
|
US5120727A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Rapamycin dimers
|
|
US5120725A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Bicyclic rapamycins
|
|
ZA924953B
(en)
|
1991-07-25 |
1993-04-28 |
Univ Louisville Res Found |
Method of treating ocular inflammation
|
|
ES2139646T3
(es)
|
1991-12-19 |
2000-02-16 |
Mitsui Chemicals Inc |
Acido polihidroxido carboxilico y su procedimiento de obtencion.
|
|
US5177203A
(en)
|
1992-03-05 |
1993-01-05 |
American Home Products Corporation |
Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
|
|
US5242910A
(en)
|
1992-10-13 |
1993-09-07 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
|
US5536729A
(en)
|
1993-09-30 |
1996-07-16 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US5527907A
(en)
|
1993-11-19 |
1996-06-18 |
Abbott Laboratories |
Macrolide immunomodulators
|
|
EP1006935B1
(en)
|
1995-06-07 |
2005-01-26 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US7833543B2
(en)
*
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US5968542A
(en)
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
|
US5989591A
(en)
|
1997-03-14 |
1999-11-23 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US6890546B2
(en)
|
1998-09-24 |
2005-05-10 |
Abbott Laboratories |
Medical devices containing rapamycin analogs
|
|
US6015815A
(en)
|
1997-09-26 |
2000-01-18 |
Abbott Laboratories |
Tetrazole-containing rapamycin analogs with shortened half-lives
|
|
US6376517B1
(en)
|
1998-08-14 |
2002-04-23 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivatives for vision and memory disorders
|
|
ATE427760T1
(de)
|
2001-02-23 |
2009-04-15 |
Genentech Inc |
Erodierbare polymere zur injektion
|
|
CN1684663A
(zh)
|
2002-07-31 |
2005-10-19 |
阿尔萨公司 |
可注射的多模式聚合物储库组合物以及其用途
|
|
DK1539157T3
(da)
|
2002-09-18 |
2013-10-07 |
Univ Pennsylvania |
Fremgangsmåde til hæmning af choroidal neovaskularisering
|
|
US20120225033A1
(en)
*
|
2010-11-24 |
2012-09-06 |
Durect Corporation |
Biodegradable Drug Delivery Composition
|
|
RU2355385C2
(ru)
|
2002-11-06 |
2009-05-20 |
Алза Корпорейшн |
Композиции пролонгированного действия с контролируемым высвобождением
|
|
ATE482695T1
(de)
|
2002-12-13 |
2010-10-15 |
Durect Corp |
Orale darreichungsform mit flüssigen hochviskosen trägersystemen
|
|
JP2007525429A
(ja)
|
2003-03-11 |
2007-09-06 |
キューエルティー ユーエスエー，インコーポレイテッド． |
細胞スケジュール依存性抗癌剤のための処方
|
|
KR20060085246A
(ko)
|
2003-09-18 |
2006-07-26 |
마커사이트, 인코포레이티드 |
경공막 전달
|
|
US7087237B2
(en)
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
AU2005287175B2
(en)
|
2004-09-17 |
2011-12-01 |
Durect Corporation |
Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
|
|
KR101341359B1
(ko)
|
2004-10-01 |
2013-12-13 |
램스코르 인코포레이티드 |
편리하게 이식가능한 서방형 약물 조성물
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
DK1848431T3
(en)
|
2005-02-09 |
2016-04-18 |
Santen Pharmaceutical Co Ltd |
LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
|
|
AU2006227116A1
(en)
|
2005-03-21 |
2006-09-28 |
Santen Pharmaceutical Co., Ltd. |
Drug delivery systems for treatment of diseases or conditions
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
KR20140093764A
(ko)
|
2006-02-09 |
2014-07-28 |
산텐 세이야꾸 가부시키가이샤 |
안정한 제제와 그 제조 및 사용 방법
|
|
ES2563288T3
(es)
|
2006-03-23 |
2016-03-14 |
Santen Pharmaceutical Co., Ltd |
Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
|
|
CN1973822A
(zh)
|
2006-12-20 |
2007-06-06 |
山东蓝金生物工程有限公司 |
一种含雷帕霉素的抗癌组合物
|
|
AU2007339280B2
(en)
|
2006-12-21 |
2013-12-05 |
Stryker Corporation |
Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents
|
|
EP2167039B1
(en)
|
2007-05-18 |
2016-09-28 |
Durect Corporation |
Improved depot formulations
|
|
ES2507078T3
(es)
|
2007-08-16 |
2014-10-14 |
Santen Pharmaceutical Co., Ltd |
Formulaciones de rapamicina para tratamiento de la degeneración macular relacionada con la edad
|
|
EP2219622A1
(en)
|
2007-12-06 |
2010-08-25 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
|
|
EP2244679A4
(en)
*
|
2008-02-08 |
2013-10-09 |
Qps Llc |
NON-POLYMERIC COMPOSITIONS FOR CONTROLLED MEDICINAL PRODUCTION
|
|
US20120114637A1
(en)
|
2009-05-04 |
2012-05-10 |
Santen Pharmaceutical Co., Ltd. |
Mtor pathway inhibitors for treating ocular disorders
|
|
EP2782590A4
(en)
|
2011-11-23 |
2016-08-03 |
Durect Corp |
BIODEGRADABLE AND MEDIUM-RADIATED STERILIZED MEDICAMENTAL COMPOSITIONS
|
|
BR112014017969A8
(pt)
|
2012-01-23 |
2017-07-11 |
Allergan Inc |
Microesferas ou micropartículas bioerodíveis ou bio-degradáveis liberadas por tempo suspensas em uma formulação de droga injetável de formação de depósito
|
|
EA033537B1
(ru)
*
|
2013-03-11 |
2019-10-31 |
Durect Corp |
Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью
|
|
TW201521769A
(zh)
|
2013-03-15 |
2015-06-16 |
Durect Corp |
具有流變改質劑以減少溶解變異性之組成物
|
|
WO2014144984A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with thixotropy and enhanced dissolution reproducibility and stability
|
|
KR102245354B1
(ko)
|
2013-05-24 |
2021-04-30 |
아이콘 바이오사이언스, 인크. |
백내장 수술 후 염증에서의 서방출 덱사메타손의 용도
|
|
CN107249570B
(zh)
|
2014-11-21 |
2022-08-09 |
丹麦技术大学 |
用于局部药物释放的凝胶制剂
|
|
US11090296B2
(en)
|
2015-03-18 |
2021-08-17 |
Santen Pharmaceutical Co., Ltd. |
Sustained-release pharmaceutical composition
|
|
CN107708738B
(zh)
|
2015-07-01 |
2022-03-25 |
参天制药株式会社 |
含有柠檬酸酯的贮库制剂
|
|
US10668011B2
(en)
|
2016-06-30 |
2020-06-02 |
Durect Corporation |
Depot formulations
|
|
WO2018128173A1
(en)
|
2017-01-06 |
2018-07-12 |
Santen Pharmaceutical Co., Ltd. |
Intratumoral administration of sirolimus for treatment of prostate cancer
|